Kyntra Bio KYNB
NASDAQ KYNB
$5.21 -0.14 (-2.70%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) EV to EBITDA (2019)

Updated

Kyntra Bio's (KYNB) EV to EBITDA came in at 64.04 for Q3 2019, down 2.5% from the prior quarter.

Analysis

Kyntra Bio (KYNB) EV to EBITDA (2019) Analysis & Trends

For the trailing twelve months through Sep 30, 2019, EV to EBITDA at Kyntra Bio was 18.81.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kyntra Bio 21.25 Mn -386.69 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 52.97
Jun 30, 2019 59.35
API Access

Kyntra Bio EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=KYNB&period=max&api_key=YOUR_API_KEY